SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is surging after announcing preliminary Q3 revenue that significantly exceeded prior guidance and analyst consensus, indicating robust demand for its AI infrastructure solutions. The community is highly bullish, anticipating sustained growth as the company plays a crucial role in the ongoing data center buildout.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following the FDA's issuance of a Complete Response Letter for its Hunter syndrome gene therapy, RGX-121, citing concerns with trial design and the appropriateness of its surrogate endpoint. The community is actively debating the broader implications for gene therapies, RGNX's financial outlook, and potential impacts on its Duchenne and AbbVie-partnered programs.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending following a drastic stock plunge driven by the abrupt departure of its CFO and general counsel, an SEC investigation into cash management, and an accounting review exposing internal control weaknesses and revised future guidance, sparking intense community debate between those foreseeing catastrophe and others viewing it as an extreme overreaction and buying opportunity.

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Satellos Bioscience Inc

MSLE is actively discussed following its recent NASDAQ listing, a reverse split, and a substantial equity raise. While optimists view the financing as a strong vote of confidence in its "revolutionary" muscle regeneration drug for Duchenne patients and foresee potential acquisition, skeptics caution about dilution and characterize early clinical data as premature hype.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is seeing significant trending activity with its community actively working to "drop a zero" from its price, driven by excitement over its AI-powered utility, new exchange listings, and ecosystem expansion on the Base chain. Community members are enthusiastically accumulating, citing its undervalued market cap and growing revenue, even amid broader crypto market volatility.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

The community is actively discussing Rocket Companies following its CEO's optimistic remarks about achieving multi-year highs in mortgage loan volume and gain-on-sale performance, leading to expectations of a significant re-rating as its integrated platform benefits from housing market normalization and industry consolidation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending after announcing strong preliminary revenue results and expanding AI-driven healthcare partnerships, which are seen as catalysts for its growth. The community is actively discussing its significant short interest and recent institutional buying, sparking debate on a potential short squeeze.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is trending sharply higher after the House passed a bill to extend ACA subsidies, fueling investor optimism for significant upside and a potential short squeeze, though community debate persists on the bill's Senate fate and the company's path to profitability ahead of its upcoming earnings.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify (SPOT) is seeing heated debate leading into its Q4 earnings report, as bullish analysts and the rollout of new AI-powered features and price hikes contend with investor concerns over its valuation and a recent music catalog leak.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing extreme volatility following a patent infringement lawsuit from Novo Nordisk and FDA scrutiny regarding its compounded semaglutide weight-loss pill, which the company has now ceased offering. The community is fiercely debating whether this represents a fundamental threat and further downside, or an overreaction presenting a significant short squeeze opportunity for a company with strong core business segments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Monday.com Stock Was Tumbling Today

Key PointsMonday.com beat fourth-quarter estimates, but its guidance came up short...

Monday.com Hits Rock Bottom: Overdone Sell-Off Ready to Rebound

monday.com is in a position to rebound after its sentiment-driven sell-off extended to new lows; institutions are accumulating...

monday.com (NASDAQ:MNDY) Shares Gap Down on Analyst Downgrade

monday.com (NASDAQ:MNDY) Shares Gap Down on Analyst Downgrade...

Monday.com drops 19% as AI disruption fears mount in software

Software companies are facing mounting pressure from disruptive AI tools threatening to replace them...

monday.com Q4 Earnings Call Highlights

monday.com (NASDAQ:MNDY) executives highlighted continued upmarket progress, expanding AI capabilities, and a more cautious near-term outlook as the company reported fourth-quarter and full-year...

monday.com (MNDY) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

<ul class="summary-bullets"><li>The AI-powered work platform provider has forecast first-quarter fiscal 2026 revenue of $338 million to $340 million, reflecting approximately 20% year-on-year growth.</li><li>In the fourth quarter, the company reported revenue of $333.9 million, a 25% year-over-year increase, and adjusted earnings per share (EPS) of $1.04.&nbsp;</li><li>Overall, the company maintained a 110% revenue retention rate from existing customers in Q4.</li></ul>Monday.com (MNDY) stock is on track to hit November 2022 lows on Monday after the company issued its first-quarter (Q1) and 2026 outlook, which came in below the Street’s expectation.&nbsp;The AI-powered work platform provider has forecast first-quarter fiscal 2026 revenue of $338 million to $340 million, reflecting approximately 20% YoY growth. For fiscal year 2026, the company projects total revenue of $1.452 billion to $1.462 billion, representing 18% to 19% YoY growth.&nbsp;However, both the Q1 and fiscal 2026 projections are below the consensus estimates of $342.87 million and $1.48 billion, respectively, according to Koyfin.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Following the earnings, M<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://monday.com">onday.com</a> stock traded over 23% lower on Monday, after the morning bell. However, on Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_02_09_090707_png_3826d2e8ea.webp" alt="MNDY’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Feb. 9, 2026 | Source: Stocktwits" width="929" height="107"><figcaption>MNDY’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Feb. 9, 2026 | Source: Stocktwits</figcaption></figure>A Stocktwits user suggested buying the fear and added that the stock could bounce 10% to 20% in a week.&nbsp;<stembedurl>https://stocktwits.com/mba1/message/644446008</stembedurl>Another bullish user lauded the company’s business model.&nbsp;<stembedurl>https://stocktwits.com/galbow/message/644444624</stembedurl><h2 class="st-heading-2">Q4 Financial Performance&nbsp;</h2>In the fourth-quarter (Q4) fiscal 2025, the company reported revenue of $333.9 million, marking a 25% year-on-year (YoY) increase, and adjusted earnings per share (EPS) of $1.04. Both revenue and EPS exceeded the analysts’ consensus estimates of $329.66 million and $0.92, respectively, according to Fiscal AI data.&nbsp;<blockquote>“While foreign exchange rates have created some near-term pressure on margins, the underlying fundamentals remain healthy, and we continue to see momentum with larger customers.”-Eliran Glazer, CFO, monday.com</blockquote><h2 class="st-heading-2">Customer Growth And AI Platform Expansion</h2>Overall, the company maintained a 110% revenue retention rate from existing customers in Q4, with clients having more than 10 users achieving 114% retention, and those generating over $50,000 or $100,000 in annual recurring revenue (ARR) reaching 116%.&nbsp;Clients with annual recurring revenue (ARR) above $50,000 rose 34% YoY, and those exceeding $100,000 climbed 45% YoY. Customers with ARR over $500,000 saw the largest YoY increase, up 74%.&nbsp;MNDY stock has declined by over 69% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ai-fear-trade-hedge-funds-biggest-bet-against-tech-goldman-sachs/cZbvGiWR4oI">AI Fear Trade? Hedge Funds Reportedly Made Their Biggest Bet Against Tech In Years, Says Goldman Sachs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Monday.com Ltd.

MNDY Stock Hits November 2022 Lows After Guidance Falls Short Of Expectation – But Retail Says 'Buy The Fear'

For fiscal year 2026, the company projects total revenue of $1.452 billion to $1.462 billion, representing 18% to 19% Year-over-Year growth. 

Equity

For fiscal year 2026, the company projects total revenue of $1.452 billion to $1.462 billion, representing 18% to 19% Year-over-Year growth. 


Futures Flat, Erase Overnight Losses As Nervous Traders Brace For Key Week

Futures Flat, Erase Overnight Losses As Nervous Traders Brace For Key Week S&P futures are unchanged, erasing all overnight losses, extending last week's choppy price action focused on AI...

Monday.com (MNDY) Q4 Earnings and Revenues Top Estimates

Monday.com (MNDY) delivered earnings and revenue surprises of +14.60% and +1.49%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

monday.com (NASDAQ:MNDY) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS

monday.com (NASDAQ:MNDY - Get Free Report) released its quarterly earnings data on Monday. The company reported $1.04 earnings per share for the quarter, beating analysts' consensus estimates of...

$MNDY Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.48 up 228.89% YoY
• Reported revenue of $333.88M up 24.59% YoY
• For full year 2026, monday.com expects total revenue of $1.45B to $1.46B, with non-GAAP operating income of $165M to $175M and adjusted free cash flow of $275 million to $290 million.

monday.com is the best AI work platform. Drive exponential execution and empower teams to expand what they achieve with an AI-powered product suite, AI agents, AI workflows, AI assistant and AI apps builder.

monday.com

monday.com | Outpace everyone with the best AI work platform

Stocktwits

Monday.com Ltd

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $1.48 up 228.89% YoY
• Reported revenue of $333.88M up 24.59% YoY
• For full year 2026, 

 expects total revenue of $1.45B to $1.46B, with non-GAAP operating income of $165M to $175M and adjusted free cash flow of $275 million to $290 million.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Robinhood Markets Inc

Stocktwits Polls

Shares plunged over 20% after reporting mixed Q4 results with better-than-expected earnings but weaker guidance and withdrawal of long-term revenue targets.

Traders are hotly debating if AI tools will make enterprise software obsolete, or if integration and established workflows will protect existing platforms from disruption.

Many believe the stock is deeply oversold at a 70%+ discount from highs and view its $1.5B cash balance as a compelling reason for a rebound buy.

Uncertainty surrounds future growth, specifically citing negative foreign exchange headwinds, weakening small-to-medium business performance, and pulled long-term outlooks.

MNDY
Monday.com Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNDY News

MNDYMonday.com Ltd